Journal of Medicinal Food,
August 2009 Issue
The purpose of the first independent, randomized, double-blind placebo study evaluated how Vemma enhanced immune function and well-being in humans.* Participants were randomly divided into two groups and received 2 ounces of Vemma or placebo each morning for 30 days. After the 30-day evaluation, the study showed favorable results in immune markers and a lowering of C-reactive protein (CRP) while taking Vemma.*
Changes in IL-1α Concentration (Immunity Marker)
The Vemma group improved their immune function in a statistically significant way.
C-reactive protein (CRP) is Reduced
in Vemma Participants
Red shaded area indicates high risk range (<1mg/L) of CRP levels. White area is low risk range of CRP levels. The Vemma group
was the only group to reduce their CRP levels from unhealthy to healthy levels.
Self Reported Health Status
100% of the Vemma group reported that they felt improvement in their health, significantly more than the control group.
